Insulin Pumps Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Insulin Pumps Pipeline Market Report Overview

An insulin pump is an insulin delivery device that administers programmed doses of insulin for diabetes management. An Insulin Pump consists of a battery-run pump, an insulin reservoir, and an infusion set with a tubing system for subcutaneous intervention. The insulin pumps pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·       Patch Pumps

·       Programmable Insulin Patch Pumps

·       Programmable Insulin Patch Pumps – Pods

·       Traditional Insulin Pumps

·       Disposable Insulin Pumps

Key Territory ·       United States

·       Europe

·       China

·       India

·       United Kingdom

Key Regulatory Paths ·       510(k)

·       CE

·       NMPA

·       ICAC

·       PMA

Leading Companies ·       AgVa Healthcare Pvt Ltd

·       AMF Medical SA

·       Amrita Vishwa Vidyapeetham

·       Andain, Inc

·       Cellnovo Ltd (Inactive)

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Insulin Pumps Pipeline Market by Segments

The key segments in the insulin pumps pipeline products market are patch pumps, programmable insulin patch pumps, programmable insulin patch pumps – pods, traditional insulin pumps, and disposable insulin pumps among others. As of May 2024, patch pumps account for the highest number of hernia repair device pipeline products.

Insulin Pumps Pipeline Market Analysis by Segments, 2024 (%)

Insulin Pumps Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Insulin Pumps Pipeline Market

Download a Free Report Sample

Insulin Pumps Pipeline Market Segmentation by Territories

A few of the key territories with the insulin pumps pipeline market are the United States, Europe, China, India, and the United Kingdom among others. As of May 2024, the US accounts for the highest number of insulin pumps pipeline products.

Insulin Pumps Pipeline Market Analysis by Territories, 2024 (%)

Insulin Pumps Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Insulin Pumps Pipeline Market

Download a Free Report Sample

Insulin Pumps Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the insulin pumps pipeline products market are 510(k), CE, NMPA, ICAC, and PMA among others. As of May 2024, 510(k) accounts for the most followed pathway for pipeline products in the insulin pumps market.

Insulin Pumps Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Insulin Pumps Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Insulin Pumps Pipeline Market

Download a Free Report Sample

Insulin Pumps Pipeline Market – Competitive Landscape

A few of the key companies associated with the insulin pumps pipeline market are AgVa Healthcare Pvt Ltd, AMF Medical SA, Amrita Vishwa Vidyapeetham, Andain, Inc., and Cellnovo Ltd (Inactive) among others.

AMF Medical SA: AMF Medical SA (AMF Medical) develops novel technology to address the unmet needs of people on insulin therapy. AMF Medical is headquartered in Ecublens, Switzerland.

Amrita Vishwa Vidyapeetham: Amrita Vishwa Vidyapeetham (AVV) is a university. It offers degree courses in the disciplines of engineering, communication, social work, and many more. It is headquartered in Coimbatore, Tamil Nadu, India.

Insulin Pumps Pipeline Market Analysis by Companies, 2024

Insulin Pumps Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Insulin Pumps Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Insulin Pumps Pipeline Market Segment Outlook (2024)

  • Patch Pumps
  • Programmable Insulin Patch Pumps
  • Programmable Insulin Patch Pumps – Pods
  • Traditional Insulin Pumps
  • Disposable Insulin Pumps

Insulin Pumps Pipeline Market Territories Outlook (2024)

  • United States
  • Europe
  • China
  • India
  • United Kingdom

Insulin Pumps Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE
  • NMPA
  • ICAC
  • PMA

Scope

This report provides:

  • Extensive coverage of the insulin pumps under development.
  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of insulin pumps and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of insulin pumps under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

AgVa Healthcare Pvt Ltd
AMF Medical SA
Amrita Vishwa Vidyapeetham
Andain, Inc
Cellnovo Ltd (Inactive)
Debiotech SA
Embecta Corp
EOFlow Co Ltd
Hospira Inc
Insulet Corp
Kailian Medical Technology Co Ltd
LifeScan Inc
MedSolve Technologies, Inc.
Medtronic MiniMed Inc
Medtronic Plc
MicroPort Scientific Corp
MicroTech Medical Inc
Modular Medical Inc
Open Medlabs Pvt Ltd
Pennsylvania State University
Pharmasens AG
Phluid Corporation
PhysioLogic Devices Inc
Qlibrium Inc
SFC Fluidics LLC
Sooil Development Co., Ltd.
Spring Health Solutions Ltd.
Tandem Diabetes Care Inc
Thermalin Inc
University of Limerick
Univlabs Technologies Pvt Ltd
Valeritas Inc
ViCentra BV
Ypsomed Holding AG

Table of Contents

1 Table of Contents 3

1.1 List of Tables 7

1.2 List of Figures 11

2 Introduction 12

2.1 Insulin Pumps Overview 12

3 Products under Development 13

3.1 Insulin Pumps – Pipeline Products by Stage of Development 13

3.2 Insulin Pumps – Pipeline Products by Segment 14

3.3 Insulin Pumps – Pipeline Products by Territory 15

3.4 Insulin Pumps – Pipeline Products by Regulatory Path 16

3.5 Insulin Pumps – Pipeline Products by Estimated Approval Date 17

3.6 Insulin Pumps – Ongoing Clinical Trials 18

4 Insulin Pumps – Pipeline Products under Development by Companies 19

4.1 Insulin Pumps Companies – Pipeline Products by Stage of Development 19

4.2 Insulin Pumps – Pipeline Products by Stage of Development 21

5 Insulin Pumps Companies and Product Overview 23

5.1 AgVa Healthcare Pvt Ltd Company Overview 23

5.1.1 AgVa Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

5.2 AMF Medical SA Company Overview 24

5.2.1 AMF Medical SA Pipeline Products & Ongoing Clinical Trials Overview 24

5.3 Amrita Vishwa Vidyapeetham Company Overview 27

5.3.1 Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview 27

5.4 Andain, Inc Company Overview 28

5.4.1 Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.5 Cellnovo Ltd (Inactive) Company Overview 30

5.5.1 Cellnovo Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30

5.6 Debiotech SA Company Overview 31

5.6.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 31

5.7 Embecta Corp Company Overview 33

5.7.1 Embecta Corp Pipeline Products & Ongoing Clinical Trials Overview 33

5.8 EOFlow Co Ltd Company Overview 39

5.8.1 EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

5.9 Hospira Inc Company Overview 40

5.9.1 Hospira Inc Pipeline Products & Ongoing Clinical Trials Overview 40

5.10 Insulet Corp Company Overview 41

5.10.1 Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview 41

5.11 Kailian Medical Technology Co Ltd Company Overview 44

5.11.1 Kailian Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 44

5.12 LifeScan Inc Company Overview 46

5.12.1 LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview 46

5.13 MedSolve Technologies, Inc. Company Overview 47

5.13.1 MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47

5.14 Medtronic MiniMed Inc Company Overview 48

5.14.1 Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview 48

5.15 Medtronic Plc Company Overview 51

5.15.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 51

5.16 MicroPort Scientific Corp Company Overview 53

5.16.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 53

5.17 MicroTech Medical Inc Company Overview 55

5.17.1 MicroTech Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 55

5.18 Modular Medical Inc Company Overview 57

5.18.1 Modular Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 57

5.19 Open Medlabs Pvt Ltd Company Overview 59

5.19.1 Open Medlabs Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 59

5.20 Pennsylvania State University Company Overview 60

5.20.1 Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview 60

5.21 Pharmasens AG Company Overview 61

5.21.1 Pharmasens AG Pipeline Products & Ongoing Clinical Trials Overview 61

5.22 Phluid Corporation Company Overview 63

5.22.1 Phluid Corporation Pipeline Products & Ongoing Clinical Trials Overview 63

5.23 PhysioLogic Devices Inc Company Overview 64

5.23.1 PhysioLogic Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 64

5.24 Qlibrium Inc Company Overview 65

5.24.1 Qlibrium Inc Pipeline Products & Ongoing Clinical Trials Overview 65

5.25 SFC Fluidics LLC Company Overview 66

5.25.1 SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview 66

5.26 Sooil Development Co., Ltd. Company Overview 69

5.26.1 Sooil Development Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 69

5.27 Spring Health Solutions Ltd. Company Overview 70

5.27.1 Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview 70

5.28 Tandem Diabetes Care Inc Company Overview 71

5.28.1 Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 71

5.29 Thermalin Inc Company Overview 76

5.29.1 Thermalin Inc Pipeline Products & Ongoing Clinical Trials Overview 76

5.30 University of Limerick Company Overview 79

5.30.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 79

5.31 Univlabs Technologies Pvt Ltd Company Overview 80

5.31.1 Univlabs Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 80

5.32 Valeritas Inc Company Overview 81

5.32.1 Valeritas Inc Pipeline Products & Ongoing Clinical Trials Overview 81

5.33 ViCentra BV Company Overview 82

5.33.1 ViCentra BV Pipeline Products & Ongoing Clinical Trials Overview 82

5.34 Ypsomed Holding AG Company Overview 84

5.34.1 Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview 84

6 Insulin Pumps- Recent Developments 86

6.1 May 15, 2024: Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer 86

6.2 May 02, 2024: Adding AI to Artificial Pancreas Enhances Efficiency, Study Finds 86

6.3 Apr 30, 2024: Cristal Study Published in the Lancet Diabetes & Endocrinology Shows Promising Outcomes for Pregnant Women Living with Type 1 Diabetes 87

6.4 Apr 30, 2024: Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum 88

6.5 Apr 24, 2024: Medtronic Names Yarmela Pavlovic as Chief Regulatory Officer 92

6.6 Apr 16, 2024: Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results 92

6.7 Apr 03, 2024: Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024 92

6.8 Apr 02, 2024: Tandem Diabetes Care Obtains Additional 510(K) Clearance For Tandem Mobi Insulin Pump With Interoperable Technology 92

6.9 Mar 25, 2024: DEKA Research and Development Receives Additional FDA 510(k) Clearance for DEKA ACE Pump System 92

6.10 Mar 20, 2024: Insulet Appoints Ana Maria Chadwick as Chief Financial Officer 93

6.11 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference 94

6.12 Mar 08, 2024: Insulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod 5 Automated Insulin Delivery System Is Superior to Pump Therapy 94

6.13 Mar 06, 2024: Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029 95

6.14 Mar 05, 2024: Insulet to Present Results From First Omnipod 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) 97

6.15 Mar 04, 2024: Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes 99

6.16 Feb 22, 2024: Medtronic to present new clinical data at ATTD on the MiniMed 780G system supporting new Time in Tight Range goals 101

6.17 Feb 22, 2024: Opentrons Announces Medical Robotics Expert Gregory Cole as Chief Innovation Officer to Accelerate AI-Driven Robo-Lab Partnerships and Innovations 103

6.18 Feb 22, 2024: Tandem Diabetes Care Reports Q4 Loss, Misses Revenue Estimates 104

6.19 Feb 15, 2024: Integer Holdings Reports Results for Fourth Quarter and Full Year 2023 104

6.20 Feb 14, 2024: Tandem introduces automated insulin delivery system 106

6.21 Feb 13, 2024: Insulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference 107

6.22 Feb 13, 2024: Roche Confirms Product Development Team Layoffs 107

6.23 Feb 09, 2024: Philip Johnson to Retire as Lilly Treasurer 107

6.24 Feb 07, 2024: Insulet Announces CE Mark Approval of Omnipod 5 Integration With Abbott Freestyle Libre 2 Plus Sensor 107

6.25 Jan 25, 2024: Johna Norton to Retire as Lilly Executive Vice President of Global Quality 108

6.26 Jan 24, 2024: Modular Medical Announces Issuance of New US Patent 108

6.27 Jan 22, 2024: Modular Medical submits MODD1 insulin pump for FDA clearance 108

6.28 Jan 10, 2024: Integer Holdings Announces Preliminary Unaudited Sales Results and Acquisition of Pulse Technologies 109

6.29 Jan 08, 2024: Tandem Diabetes Care’s t:slim X2 Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre 2 Plus Sensor 110

6.30 Jan 04, 2024: Triple Jump Israel Receives 510(k) Clearance for Insulin Patch Pump 111

6.31 Dec 12, 2023: Tandem Diabetes Care Announces Full U.S. Launch of Tandem Source, a New Diabetes Management Platform for Customers and Healthcare Providers 111

6.32 Dec 06, 2023: Tandem Diabetes Care Launches t:slim X2 Insulin Pump Software with Dexcom G7 CGM Integration in U.S. 112

6.33 Nov 15, 2023: Tandem Diabetes Care Receives Additional 510(K) Clearance For T:slim X2 Insulin Pump With Interoperable Technology 113

6.34 Nov 15, 2023: Tandem Diabetes Care Receives 510(K) Clearance For t:slim X2 Control-IQ System – Adults 113

6.35 Nov 14, 2023: Tandem Diabetes Care Receives Additional 510(K) Clearance For t:slim X2 Control-IQ System – Pediatrics 113

6.36 Nov 14, 2023: Modular Medical to Attend the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference 114

6.37 Nov 10, 2023: Microport Appointment of Director 114

6.38 Nov 02, 2023: Insulet Receives Additional 510(k) Clearance for Omnipod 5 ACE Pump 115

6.39 Oct 31, 2023: Modular Medical Updates Test Progress and Submission Timeline 115

6.40 Oct 26, 2023: Tandem Diabetes Care Receives Additional 510(K) Clearance For Tandem Mobi Insulin Pump With Interoperable Technology 115

6.41 Oct 26, 2023: Integer Holdings Reports Third Quarter 2023 Results 116

6.42 Oct 26, 2023: Lilly to Participate in UBS Biopharma Conference 2023 117

6.43 Oct 20, 2023: Lilly Confirms Date and Conference Call for Third-Quarter 2023 Financial Results Announcement 118

6.44 Oct 18, 2023: Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range 118

6.45 Oct 10, 2023: Tandem Diabetes Care to Announce Third Quarter 2023 Financial Results on November 1, 2023 120

6.46 Oct 05, 2023: Medtronic Real-World Evidence Demonstrates Consistent Results of the Minimed 780G Regardless of Demographic or Cultural Differences 120

6.47 Oct 04, 2023: Lilly Announces Leadership Transitions 121

6.48 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business 122

6.49 Oct 03, 2023: Insulet Announces CFO Transition 123

6.50 Oct 03, 2023: Samuel Kunzli succeeds Niklaus Ramseier as CFO and member of the Executive Board 123

6.51 Sep 29, 2023: Samuel Kunzli succeeds Niklaus Ramseier as CFO and member of the Executive Board 124

6.52 Sep 29, 2023: Samuel Kunzli Succeeds Niklaus Ramseier as CFO and Member of the Executive Board 124

6.53 Sep 28, 2023: Integer Schedules Third Quarter 2023 Earnings Release and Conference Call for October 26, 2023 124

6.54 Sep 21, 2023: Microport Scientific Corp. Announces 2023 Interim Report 125

6.55 Sep 04, 2023: DexCom launches connected CGM system with new AID feature in Germany 127

6.56 Aug 28, 2023: Insulet Announces Full Market Release of Omnipod 5 Automated Insulin Delivery System in Germany 128

6.57 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 128

6.58 Aug 23, 2023: Roche Diabetes Care Receives 510(k) Clearance for Accu-Chek Solo Micropump System 129

6.59 Aug 15, 2023: Convatec Group Appoints Robyn Butler-Mason as Company Secretary 129

6.60 Aug 10, 2023: DEKA Research and Development Receives 510(k) Clearance for DEKA ACE Pump System 129

6.61 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 129

6.62 Aug 03, 2023: Tandem Diabetes Care Announces Technology Access Program to Provide Customers With Purchase Pathway to the Tandem Mobi System 130

6.63 Aug 02, 2023: ConvaTec Group Announces Interim Results for the six months ended 30 June 2023 131

6.64 Jul 27, 2023: F. Hoffmann-La Roche Announces Half Year Results 2023 131

6.65 Jul 20, 2023: SFC Fluidics Receives $2 Million SBIR Grant to Develop Groundbreaking Dual Hormone System for Diabetes Care 132

6.66 Jul 13, 2023: World’s smallest insulin pump granted FDA clearance 132

6.67 Jul 11, 2023: Microport Scientific Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023 133

6.68 Jul 05, 2023: Insulet to Announce Second Quarter 2023 Financial Results on August 8, 2023 133

6.69 Jun 22, 2023: Dexcom G6 adds another compatible AID system after Omnipod 5 launch 133

6.70 Jun 22, 2023: Insulet Celebrates One Year of Omnipod 5 at the American Diabetes Association 83rd Scientific Sessions 134

6.71 Jun 12, 2023: Medtronic to present new data on its intelligent dosing platforms at the American Diabetes Association 83rd Scientific Sessions 136

6.72 Jun 12, 2023: Abbott Names Philip Boudreau CFO effective Sept. 1 138

7 Appendix 139

7.1 Methodology 139

7.2 About GlobalData 142

7.3 Contact Us 142

7.4 Disclaimer 142

Table

Insulin Pumps – Pipeline Products by Stage of Development 13

Insulin Pumps – Pipeline Products by Segment 14

Insulin Pumps – Pipeline Products by Territory 15

Insulin Pumps – Pipeline Products by Regulatory Path 16

Insulin Pumps – Pipeline Products by Estimated Approval Date 17

Insulin Pumps – Ongoing Clinical Trials 18

Insulin Pumps Companies – Pipeline Products by Stage of Development 19

Insulin Pumps – Pipeline Products by Stage of Development 21

AgVa Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

Insul – Product Status 23

Insul – Product Description 23

AMF Medical SA Pipeline Products & Ongoing Clinical Trials Overview 24

Sigi Patch Pump – Product Status 24

Sigi Patch Pump – Product Description 24

AMF Medical SA – Ongoing Clinical Trials Overview 25

Sigi Patch Pump – Sigi Insulin Management System – First-in-Human Study 26

Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview 27

Amrita Insulin Pump – Product Status 27

Amrita Insulin Pump – Product Description 27

Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 28

Gaia Med Diamond Semi-Disposable Pump – Product Status 28

Gaia Med Diamond Semi-Disposable Pump – Product Description 28

Gemini Pump – Product Status 29

Gemini Pump – Product Description 29

Cellnovo Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30

Wireless Insulin Pump System Integrated With inControl AP – Product Status 30

Wireless Insulin Pump System Integrated With inControl AP – Product Description 30

Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 31

JewelPump – Product Status 31

JewelPump – Product Description 31

JewelPUMP2 – Product Status 32

JewelPUMP2 – Product Description 32

Embecta Corp Pipeline Products & Ongoing Clinical Trials Overview 33

Closed-Loop Patch Pump with Insulin-Dosing Algorithm – Product Status 33

Closed-Loop Patch Pump with Insulin-Dosing Algorithm – Product Description 34

Open-Loop Insulin Patch Pump – Product Status 34

Open-Loop Insulin Patch Pump – Product Description 34

Tubed Patch Pump With T2D Insulin Control Algorithm – Product Status 35

Tubed Patch Pump With T2D Insulin Control Algorithm – Product Description 35

Tubeless Patch Pump With T2D Insulin Control Algorithm – Product Status 35

Tubeless Patch Pump With T2D Insulin Control Algorithm – Product Description 36

Type 2 Patch Pump – Product Status 36

Type 2 Patch Pump – Product Description 36

Embecta Corp – Ongoing Clinical Trials Overview 37

Closed-Loop Patch Pump with Insulin-Dosing Algorithm – A Randomized, Controlled, Crossover Trial to Assess a Fully Automated, Dual-hormone (Insulin-and-pramlintide) Delivery System Without Carbohydrate Counting in Regulating Glucose Levels in Adults With Type 1 Diabetes. 38

EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

EOPatch 3.0 – Product Status 39

EOPatch 3.0 – Product Description 39

Hospira Inc Pipeline Products & Ongoing Clinical Trials Overview 40

Integrated Symbiq/EndoTool System – Product Status 40

Integrated Symbiq/EndoTool System – Product Description 40

Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview 41

Omnipod GO – Product Status 41

Omnipod GO – Product Description 42

Omnipod U-200 Insulin Management System – Product Status 42

Omnipod U-200 Insulin Management System – Product Description 42

Omnipod U-500 Insulin Management System – Product Status 43

Omnipod U-500 Insulin Management System – Product Description 43

Kailian Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 44

InnoTouch Insulin Application Pump – Product Status 44

InnoTouch Insulin Application Pump – Product Description 44

Le Pump Insulin Pump II – Product Status 45

Le Pump Insulin Pump II – Product Description 45

Lenomed ATA-I-1-0 Insulin Pump – Product Status 45

Lenomed ATA-I-1-0 Insulin Pump – Product Description 45

LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview 46

ONETOUCH Ping Verio Insulin Pump With Meter Remote – Product Status 46

ONETOUCH Ping Verio Insulin Pump With Meter Remote – Product Description 46

MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47

Freehand Patch Pump – Product Status 47

Freehand Patch Pump – Product Description 47

Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview 48

MiniMed 780G System With Simplera Sync Sensor – Product Status 48

MiniMed 780G System With Simplera Sync Sensor – Product Description 48

Medtronic MiniMed Inc – Ongoing Clinical Trials Overview 49

MiniMed 780G System With Simplera Sync Sensor – Closed Loop and Education for Hypoglycemia Awareness Restoration (CLEAR), Conducted by the Impaired Awareness of Hypoglycemia Consortium (IAHC) (CLEAR) 50

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 51

EOPatch Wearable Insulin Pump System – Product Status 51

EOPatch Wearable Insulin Pump System – Product Description 52

Implantable Insulin Pump – Product Status 52

Implantable Insulin Pump – Product Description 52

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 53

Angel Touch – Product Status 53

Angel Touch – Product Description 53

La Fenice V – Product Status 54

La Fenice V – Product Description 54

MicroTech Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 55

Equil Insulin Pump – Child and Adolescent Use – Product Status 55

Equil Insulin Pump – Child and Adolescent Use – Product Description 55

Second-Generation Patch Insulin Pump System – Product Status 56

Second-Generation Patch Insulin Pump System – Product Description 56

Modular Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 57

MODD1 (MODD Pivot) – Product Status 57

MODD1 (MODD Pivot) – Product Description 58

MODD1+ – Product Status 58

MODD1+ – Product Description 58

Open Medlabs Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 59

InsuFlo – Product Status 59

InsuFlo – Product Description 59

Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview 60

Nanobot Based Insulin Pumping Device – Product Status 60

Nanobot Based Insulin Pumping Device – Product Description 60

Pharmasens AG Pipeline Products & Ongoing Clinical Trials Overview 61

niia Advanced Pump System – Product Status 61

niia Advanced Pump System – Product Description 61

niia Essential Insulin Patch Pump System – Product Status 62

niia Essential Insulin Patch Pump System – Product Description 62

Phluid Corporation Pipeline Products & Ongoing Clinical Trials Overview 63

Ambulatory Diabetes Pump – Product Status 63

Ambulatory Diabetes Pump – Product Description 63

PhysioLogic Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 64

ThinPump – Product Status 64

ThinPump – Product Description 64

Qlibrium Inc Pipeline Products & Ongoing Clinical Trials Overview 65

QForma – Product Status 65

QForma – Product Description 65

SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview 66

Dual ePump – Product Status 66

Dual ePump – Product Description 66

Open-Protocol Patch Pump System – Product Status 67

Open-Protocol Patch Pump System – Product Description 67

PANDA – Product Status 67

PANDA – Product Description 68

Pod Automated Insulin Delivery Device – Product Status 68

Pod Automated Insulin Delivery Device – Product Description 68

Sooil Development Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 69

Dana-I Pump – Product Status 69

Dana-I Pump – Product Description 69

Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview 70

Spring Zone Hybrid Patch Pump – Product Status 70

Spring Zone Hybrid Patch Pump – Product Description 70

Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 71

SteadiSet Infusion Set – Product Status 71

SteadiSet Infusion Set – Product Description 71

t:slim X3 Insulin Pump – Product Status 72

t:slim X3 Insulin Pump – Product Description 72

Tandem Mobi: Tubeless – Product Status 72

Tandem Mobi: Tubeless – Product Description 73

Tandem Diabetes Care Inc – Ongoing Clinical Trials Overview 74

SteadiSet Infusion Set – Open, Single Arm, Prospective, Multicenter Study of an Investigational Extended Wear Insulin Infusion Set During Home Use in People with Type 1 Diabetes 75

Thermalin Inc Pipeline Products & Ongoing Clinical Trials Overview 76

Stabilized and Ultra-Rapid Insulin Pump – Product Status 76

Stabilized and Ultra-Rapid Insulin Pump – Product Description 76

StampPump – Product Status 77

StampPump – Product Description 77

Ultra-Rapid Highly-Concentrated Insulin Pump – Product Status 77

Ultra-Rapid Highly-Concentrated Insulin Pump – Product Description 78

University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 79

Smart Gluco – Product Status 79

Smart Gluco – Product Description 79

Univlabs Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 80

Wearable Insulin Patch Pump – Product Status 80

Wearable Insulin Patch Pump – Product Description 80

Valeritas Inc Pipeline Products & Ongoing Clinical Trials Overview 81

V-Go SIM – Product Status 81

V-Go SIM – Product Description 81

ViCentra BV Pipeline Products & Ongoing Clinical Trials Overview 82

Kaleido Hybrid Closed Loop System – Product Status 82

Kaleido Hybrid Closed Loop System – Product Description 82

Kaleido Insulin Pump – Children And Adolescent – Product Status 83

Kaleido Insulin Pump – Children And Adolescent – Product Description 83

Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview 84

mylife YpsoPump 2.0 With Integrated CGM – Product Status 84

mylife YpsoPump 2.0 With Integrated CGM – Product Description 84

YpsoPod – Product Status 85

YpsoPod – Product Description 85

Glossary 141

Figures

Insulin Pumps – Pipeline Products by Stage of Development 13

Insulin Pumps – Pipeline Products by Segment 14

Insulin Pumps – Pipeline Products by Territory 15

Insulin Pumps – Pipeline Products by Regulatory Path 16

Insulin Pumps – Pipeline Products by Estimated Approval Date 17

Insulin Pumps – Ongoing Clinical Trials 18

Frequently asked questions

Insulin Pumps Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Insulin Pumps Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Insulin Pumps Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Insulin Pumps Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.